Furthermore, the incident involving He Miao underscores the need for continuous efforts to promote ethical behavior and integrity in the financial sector. Financial institutions must prioritize ethical conduct, compliance with regulations, and accountability to ensure the stability and sustainability of the banking industry.
In a groundbreaking moment for China's domestic beauty industry, Mao Geping Cosmetics soared an impressive 60% on its first day of trading on the stock market. This significant surge not only demonstrates the growing strength and confidence of Chinese beauty brands but also marks a new milestone in the global beauty market.
So mark your calendars and get ready to confront your deepest fears – because death is coming back in a big way with the highly-anticipated release of "Final Destination 6." Don't miss out on this epic return to the world of terror and suspense that has captivated audiences for over a decade. Get ready to face your final destination.In the end, whether Mbappé is the most overrated player in football is a matter of personal opinion. What is clear, however, is that he is a supremely talented player with the potential to become one of the all-time greats. By stepping out of his comfort zone and embracing new challenges, Mbappé may yet prove his critics wrong and cement his legacy as a truly exceptional player. The wall of doubt may be looming large, but with the right mindset and determination, Mbappé has the tools to break through and reach new heights in his career. Only time will tell if he is truly the most overrated player or if he is simply on the cusp of greatness, waiting to fulfill his immense potential.Warriors proving lessons can be slow to learn after consecutive lossesBy proclaiming that regret is the ultimate truth of life, Cai Guo-Qiang offers a poignant reflection on the human condition. Regret, a universal emotion that plagues individuals at various points in their lives, serves as a poignant reminder of our fallibility and the inherent complexities of human nature. It is through our regrets that we confront our deepest vulnerabilities and grapple with the consequences of our choices.
TSMC's 2nm Chip Production Yield Exceeds 60% and Expected to Enter Mass Production Next Year with Smooth Trial Progress
AMGEN ANNOUNCES 2025 FIRST QUARTER DIVIDENDCouncil approves change orders for new utilities field office buildingPENN LAIRD — Brady Hoover isn’t one who enjoys the spotlight. The Spotswood senior pitching ace prefers to keep to himself and doesn’t enjoy having the attention of everyone around him. However, the attention was all on Hoover on Thursday afternoon at SHS as he signed his letter of intent to play baseball at Longwood University next season. While the environment isn’t to his liking, Hoover couldn’t help but crack a smile and be appreciative of his family, friends, and coaches being in attendance for the special day. “It’s still an extremely special moment to me,” Hoover said. “It means a lot. Even though I hate these kinds of environments, I don’t like speaking out in front of everyone, it’s still extremely special.” Hoover visited a number of different colleges, but the first time he visited Longwood, he knew it was where he wanted to be. “All the other visits felt a little shaky,” Hoover said. “This one truly felt like home. I love the coaching staff, love the guys there. I just love everything about Longwood.” Hoover had many people to thank who have played integral parts in his journey and helped him achieve a childhood dream of playing baseball at the collegiate level. One of those include Spotswood head coach Marcus Davis, who Hoover said has been one of his greatest mentors. “I see him as part of family, honestly,” Hoover said. “I’m with him almost every day and he’s taught me a lot about pitching. He’s a great guy.” Seeing one of his players sign with a D-1 school is why Davis coaches. It’s his job, he said, to help develop players and push them to reach their full potential. When it comes to Hoover, Davis didn’t have any doubts on what he could achieve. “It’s never been a shadow of a doubt what he wanted to attain and then along the way, he’s learned how to put the work in to get where he is today,” Davis said. “I don’t want to take any credit for that. I just do my small piece of helping develop Brady. He’s got to do all the hard work, and he’s done that. I’m super excited for him.” Over the course of Hoover’s career, Davis said he learned to put in work independently, and believes that played a key role in leading him to the sport’s next level. “It’s been cool to see him embrace the game, fall in love with the game, and put time in without anybody having to force him to do it,” Davis said. “I think that’s what makes a difference between a Division I athlete and a kid that’s just out there playing the game.” When Hoover entered the Trailblazers varsity program as a freshman, he had the talent on the bump, but didn’t have the mental game he needed. Over time, Hoover said he’s been able to grow in that aspect and it’s made him into the player he is today. “My coaches have always talked me through it,” Hoover said. “Always told me that I needed to have confidence in myself. I finally gained that.” Davis said Hoover has always had calmness on the field, and believes his confidence is exuded through lack of emotion. It took awhile for Davis to learn that about Hoover as it initially came off as a nonchalant attitude. When in reality, Davis said that’s just how Hoover performs to his best. “Some guys demonstrate more antics, that’s not Brady,” Hoover said. “He’s just calm, cool, collected, and just goes about his business. He’s kinda always had that, but he’s matured in how he applies and how competitive he still is without showing all that outward emotion.” Hoover knows Longwood is in his future, but he still has one year remaining with the Blazers. In his final year suiting up for Spotswood, Hoover hopes they can make a name for themselves and silence any doubters on what they can accomplish. “Everyone sees us as, ‘Oh, that 2021-2022 team,’” Hoover said. “No. We have different goals. We have better goals. I see us going for a state championship run this year.”
Social media users are misrepresenting a report released Thursday by the Justice Department inspector general's office, falsely claiming that it's proof the FBI orchestrated the Capitol riot on Jan. 6, 2021. The watchdog report examined a number of areas, including whether major intelligence failures preceded the riot and whether the FBI in some way provoked the violence. Claims spreading online focus on the report's finding that 26 FBI informants were in Washington for election-related protests on Jan. 6, including three who had been tasked with traveling to the city to report on others who were potentially planning to attend the events. Although 17 of those informants either entered the Capitol or a restricted area around the building during the riot, none of the 26 total informants were authorized to do so by the bureau, according to the report. Nor were they authorized to otherwise break the law or encourage others to do so. Here's a closer look at the facts. CLAIM: A December 2024 report released by the Department of Justice's Office of the Inspector General is proof that the Jan. 6 Capitol riot was a setup by the FBI. THE FACTS: That's false. The report found that no undercover FBI employees were at the riot on Jan. 6 and that none of the bureau's informants were authorized to participate. Informants, also known as confidential human sources, work with the FBI to provide information, but are not on the bureau’s payroll. Undercover agents are employed by the FBI. According to the report, 26 informants were in Washington on Jan. 6 in connection with the day's events. FBI field offices only informed the Washington Field Office or FBI headquarters of five informants that were to be in the field on Jan. 6. Of the total 26 informants, four entered the Capitol during the riot and an additional 13 entered a restricted area around the Capitol. But none were authorized to do so by the FBI, nor were they given permission to break other laws or encourage others to do the same. The remaining nine informants did not engage in any illegal activities. None of the 17 informants who entered the Capitol or surrounding restricted area have been prosecuted, the report says. A footnote states that after reviewing a draft of the report, the U.S. attorney's office in Washington said that it “generally has not charged those individuals whose only crime on January 6, 2021 was to enter restricted grounds surrounding the Capitol, which has resulted in the Office declining to charge hundreds of individuals; and we have treated the CHSs consistent with this approach.” Related: The assistant special agent in charge of the Washington Field Office's counterterrorism division told the inspector general's office that he “denied a request from an FBI office to have an undercover employee engage in investigative activity on January 6.” He, along with then-Washington Field Office Assistant Director in Charge Steven D'Antuono, said that FBI policy prohibits undercover employees at First Amendment-protected events without investigative authority. Many social media users drew false conclusions from the report's findings. READ: “JANUARY 6th WAS A SETUP!" reads one X post that had received more than 11,400 likes and shares as of Friday. “New inspector general report shows that 26 FBI/DOJ confidential sources were in the crowd on January 6th, and some of them went into the Capitol and restricted areas. Is it a coincidence that Wray put in his resignation notice yesterday? TREASON!” The mention of Wray's resignation refers to FBI Director Christopher Wray's announcement Wednesday that he plans to resign at the end of President Joe Biden's term in January. Other users highlighted the fact that there were 26 FBI informants in Washington on Jan. 6, but omitted key information about the findings of the report. These claims echo a fringe conspiracy theory advanced by some Republicans in Congress that the FBI played a role in instigating the events of Jan. 6, 2021, when rioters determined to overturn Republican Donald Trump's 2020 election loss to Democrat Joe Biden stormed the Capitol in a violent clash with police. The report knocks that theory down. Wray called such theories “ludicrous” at a congressional hearing last year. Asked for comment on the false claims spreading online, Stephanie Logan, a spokesperson for the inspector general’s office, pointed The Associated Press to a press release about the report. In addition to its findings about the the FBI's involvement on Jan. 6, the report said that the FBI, in an action its now-deputy director described as a “basic step that was missed,” failed to canvass informants across all 56 of its field offices for any relevant intelligence ahead of time. That was a step, the report concluded, “that could have helped the FBI and its law enforcement partners with their preparations in advance of January 6.” However, it did credit the bureau for preparing for the possibility of violence and for trying to identify known “domestic terrorism subjects” who planned to come to Washington that day. The FBI said in a letter responding to the report that it accepts the inspection general’s recommendation “regarding potential process improvements for future events.” — Find AP Fact Checks here: https://apnews.com/APFactCheck . Copyright 2024 The Associated Press . All rights reserved. This material may not be published, broadcast, rewritten or redistributed.The Similarities Between the Current Mbappe and Barcelona's Record Signing of 140 MillionLONGMONT, Colo. , Nov. 25, 2024 /PRNewswire/ -- S&W Seed Company (Nasdaq: SANW ) today announced it has finalized the voluntary plan of administration ("VA") process for its subsidiary, S&W Seed Company Australia Pty Ltd ("S&W Australia"). "As a result of the VA process being completed, on a go forward basis S&W is exclusively focused on its core U.S.-based operations led by our high margin Double Team sorghum solutions as well as our biofuels joint venture with Shell," commented S&W Seed Company's CEO, Mark Herrmann . As previously reported, S&W Australia adopted a voluntary administration process on July 24, 2024 , and on October 11, 2024 creditors of S&W Australia approved a proposed Deed of Company Arrangement ("DOCA") pursuant to which, among other things, 100% of the shares in S&W Australia would be transferred to Avior Asset Management No. 3 Pty Ltd. The effective date of the DOCA is November 22 , 2024. In order to facilitate the satisfaction of certain conditions to the effectiveness of the DOCA, on November 22, 2024 , S&W entered into a settlement agreement in exchange for a release from the intercompany obligations owed to S&W Australia. S&W will transfer ownership of certain white clover and alfalfa (lucerne) intellectual property, provide the associated inventory, repay insurance proceeds received on behalf of S&W Australia, and provide transitional support to S&W Australia necessary to assist in the changeover of business operations to a standalone entity. S&W also entered into an agreement with National Australia Bank Limited that releases S&W from the AUD $15.0 million guarantee and obtained a release of certain applicable liens from CIBC Bank USA . Vanessa Baughman , CFO of S&W Seed Company, commented, "The effectuation of the DOCA has resulted in providing the resources we believe are needed to create a going concern for all entities." About S&W Seed Company Founded in 1980, S&W is a global multi-crop, middle-market agricultural company headquartered in Longmont, Colorado . S&W's vision is to be the world's preferred proprietary seed company which supplies a range of sorghum, forage and specialty crop products that supports the growing global demand for animal proteins and healthier consumer diets. S&W is a global leader in alfalfa and proprietary sorghum seeds with significant research and development, production and distribution capabilities. S&W also is focused on sustainable biofuel feedstocks primarily within camelina through its partnership. For more information, please visit www.swseedco.com . Safe Harbor Statement This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "ability," "believe," "may," "future," "plan," "intends" "should" or "expects." Forward-looking statements in this release include, but are not limited to: our belief that the effectuation of the DOCA has resulted in providing the resources necessary for S&W to continue as a "going concern." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including risks and uncertainties related to: market adoption of products designed to support the energy transition and customer demand for our partnership's products; the effects of unexpected weather and geopolitical and macroeconomic events, such as global inflation, bank failures, supply chain disruptions, uncertain market conditions, the armed conflict in Sudan , the import ban on alfalfa seed in Saudi Arabia , the ongoing military conflict between Russia and Ukraine and related sanctions and the conflict in the Middle East , on our business and operations as well as those of our partnership, and the extent to which they disrupt the local and global economies, as well as our business and the businesses of our partnership, our customers, distributors and suppliers; sufficiency of our partnership's cash and access to capital in order to develop its business; the sufficiency of our cash and access to capital in order to meet our liquidity needs, including our ability to pay our growers as our payment obligations come due; our need to comply with the financial covenants included in our loan agreements, refinance certain of our credit facilities and raise additional capital in the future and our ability to continue as a "going concern"; changes in market conditions, including any unexpected decline in commodity prices, may harm our results of operations and revenue outlook; our proprietary seed trait technology products, including Double Team, may not yield their anticipated benefits, including with respect to their impact on revenues and gross margins; changes in the competitive landscape and the introduction of competitive products may negatively impact our results of operations; demand for our Double Team sorghum solution may not be as strong as expected; our business strategic initiatives may not achieve the expected results; previously experienced logistical challenges in shipping and transportation of our products may become amplified, delaying our ability to recognize revenue and decreasing our gross margins; we may be unable to achieve our goals to drive growth, improve gross margins and reduce operating expenses; the inherent uncertainty and significant judgments and assumptions underlying our financial guidance; and the risks associated with our ability to successfully optimize and commercialize our business. These and other risks are identified in our filings with the Securities and Exchange Commission, including, without limitation, our Annual Report on Form 10-K for the year ended June 30, 2024 and in other filings subsequently made by us with the Securities and Exchange Commission. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. We do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise. Company Contact: Mark Herrmann , Chief Executive Officer S&W Seed Company Phone: (720) 593-3570 www.swseedco.com Investor Contact: Robert Blum Lytham Partners, LLC Phone: (602) 889-9700 [email protected] www.lythampartners.com SOURCE S&W Seed Company
**TSMC's 2nm Chip Production Progressing Smoothly, Expected to Enter Mass Production Next Year**Trump’s Defense secretary nominee has close ties to Idaho Christian nationalists
Hut 8 Mining stock hits 52-week high at $28.48 amid crypto surgeThe UEFA Champions League is set to witness an intense clash in the early hours of the 11th, as Spanish giants Real Madrid go head-to-head with Serie A leaders in what promises to be an epic battle on the pitch. Real Madrid, one of the most successful clubs in the history of European football, will have their work cut out for them as they face off against the toughest challenge they have encountered in the group stage so far.
THOUSAND OAKS, Calif. , Dec. 10, 2024 /PRNewswire/ -- Amgen (NASDAQ: AMGN ) today announced that its Board of Directors declared a $2.38 per share dividend for the first quarter of 2025. The dividend will be paid on March 7, 2025 , to all stockholders of record as of the close of business on February 14, 2025 . About Amgen Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions . Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average ® , and it is also part of the Nasdaq-100 Index ® , which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. For more information, visit Amgen.com and follow Amgen on X , LinkedIn , Instagram , TikTok , YouTube and Threads . Forward-Looking Statements This news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company (including BeiGene, Ltd. or Kyowa Kirin Co., Ltd.), the performance of Otezla® (apremilast) (including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion), our acquisitions of Teneobio, Inc., ChemoCentryx, Inc., or Horizon Therapeutics plc (including the prospective performance and outlook of Horizon's business, performance and opportunities, any potential strategic benefits, synergies or opportunities expected as a result of such acquisition, and any projected impacts from the Horizon acquisition on our acquisition-related expenses going forward), as well as estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes, effects of pandemics or other widespread health problems on our business, outcomes, progress, and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise. No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Our results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments involving current and future products, sales growth of recently launched products, competition from other products including biosimilars, difficulties or delays in manufacturing our products and global economic conditions. In addition, sales of our products are affected by pricing pressure, political and public scrutiny and reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We or others could identify safety, side effects or manufacturing problems with our products, including our devices, after they are on the market. Our business may be impacted by government investigations, litigation and product liability claims. In addition, our business may be impacted by the adoption of new tax legislation or exposure to additional tax liabilities. If we fail to meet the compliance obligations in the corporate integrity agreement between us and the U.S. government, we could become subject to significant sanctions. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, or we may fail to prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico , and also depend on third parties for a portion of our manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, such as COVID-19, and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials for our manufacturing activities, the distribution of our products, the commercialization of our product candidates, and our clinical trial operations, and any such events may have a material adverse effect on our product development, product sales, business and results of operations. We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our marketed products as well as for the discovery and development of new products. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to collaborate with or acquire other companies, products or technology, and to integrate the operations of companies or to support the products or technology we have acquired, may not be successful. There can be no guarantee that we will be able to realize any of the strategic benefits, synergies or opportunities arising from the Horizon acquisition, and such benefits, synergies or opportunities may take longer to realize than expected. We may not be able to successfully integrate Horizon, and such integration may take longer, be more difficult or cost more than expected. A breakdown, cyberattack or information security breach of our information technology systems could compromise the confidentiality, integrity and availability of our systems and our data. Our stock price is volatile and may be affected by a number of events. Our business and operations may be negatively affected by the failure, or perceived failure, of achieving our environmental, social and governance objectives. The effects of global climate change and related natural disasters could negatively affect our business and operations. Global economic conditions may magnify certain risks that affect our business. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all. CONTACT: Amgen, Thousand Oaks Elissa Snook , 609-251-1407 (media) Justin Claeys , 805-313-9775 (investors) SOURCE AmgenSara's chief of staff says several individuals barged into her detention room in the middle of the night
Official Notification: Multiple Fainting Incidents in the Women's Bathing Area of Public Bathhouse, Center Shut Down for Rectification
However, no show is without its flaws. While "I Am a Detective" excels in its depiction of investigative procedures and character development, some critics have pointed out certain clichés and predictable plot twists that detract from its overall impact. Additionally, the pacing of the series can sometimes feel uneven, with certain episodes dragging on while others rush through important developments. These shortcomings may have contributed to the slightly lower rating on Douban.By Molly Farrar Patriots safety and captain Jabrill Peppers will face a jury in January after allegedly assaulting a woman in October, but he might be back on the field as early as this weekend. Peppers, who last appeared in late September for the Patriots’ Week 4 game against the 49ers, was arrested Oct. 5 and charged with domestic assault and battery, assault and battery with a dangerous weapon, strangulation, and possession of a Class B substance. Peppers pleaded not guilty to all charges. His jury trial was scheduled last week to begin Jan. 22. His lawyer, Marc Brofsky, declined to comment Monday afternoon. Peppers is accused of choking a woman and pushing her head against a wall in his apartment before forcing her from his apartment, according to police records . Police also found a small bag of white powder in his wallet; Peppers allegedly admitted it was cocaine and tested positive for the drug. Previously, Brofsky has indicated that there is video evidence that “completely contradicts the alleged victim’s story.” “I expect my client to be fully exonerated,” he told a Boston 25 News reporter after a hearing last month. Peppers was placed on the Commissioner’s Exempt list three days after his arrest, which is a temporary designation that restricts players from attending practice or competing in weekly games. While on the list, players are still paid. Peppers was removed from the list Monday, the NFL announced. The Patriots are set to play the Colts in Foxborough Sunday which could be Peppers’ return to the field. “In accordance with the Personal Conduct Policy, the league initiated a preliminary investigation into an incident from early October,” the announcement said, according to multiple reports . “That review will remain ongoing and is not affected by this change in Peppers’ roster status.” A civil suit was filed against Peppers in Norfolk Superior Court last week. Representation for the NFL player and the alleged victim, who is not identified in court filings, are discussing a potential settlement, according to her lawyer. Wigdor LLP, who said on X they represent the woman, released a statement following what they called false claims about her motives from Brofsky. According to MassLive , Brofsky said the alleged victim “demand(ed) $10.5 million to settle this case, or else she would file a civil suit.” He added that “while it’s technically not extortion... it tells the court what this case is about.” “As Mr. Peppers’ lawyer has raised this, we can confirm that Mr. Peppers’ lawyer asked us to meet to discuss a potential settlement and asked us to convey a settlement proposal,” Wigdor wrote in a statement . “We did not present a proposal of $10.5 million to avoid a civil lawsuit and the civil lawsuit does not seek any particular amount other than what a jury decides to award.” Molly Farrar Molly Farrar is a general assignment reporter for Boston.com, focusing on education, politics, crime, and more. Boston.com Today Sign up to receive the latest headlines in your inbox each morning. Be civil. Be kind.
Exciting news for all fans of the acclaimed RPG "Echoes of Destiny" as the developers have officially announced the upcoming release of a highly anticipated DLC pack. This new expansion promises to bring an array of fresh challenges and adventures to the already immersive gaming experience, with over 40 new enemies set to test players' skills and strategies like never before.